Brightspring Health Services Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Brightspring Health Services Inc 's ROA in the second quarter of 2026?
Brightspring Health Services Inc achieved a return on average assets (ROA) of 5.93 % in its second quarter of 2026 a new company high.

Despite the company's net income deteriorating, Brightspring Health Services Inc was able to improve its ROA compared to the first quarter of 2026.

However, within the Healthcare sector 143 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 1172, from total ROA ranking in the first quarter of 2026 at 1843.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	5.61 %	9.33 %	19.31 %	6.69 %	8.46 %
Y / Y Net Income Change	205.75 %	412.27 %	401.95 %	-	41.67 %
Net Income (TTM) in million	365	309	189	127	63
Return On Assets (TTM)	5.93 %	5.08 %	3.18 %	2.24 %	1.13 %
BTSG's Total Ranking	# 1172	# 1843	# 1811	# 2134	# 2199
Total Assets (TTM) in million	6,102	6,213	6,421	5,892	5,778
Seq. Total Assets Change	-1.79 %	-3.23 %	8.98 %	1.97 %	1.67 %
Seq. Net Income Change	-43.34 %	92.2 %	39.97 %	100.57 %	-5.06 %

BTSG's 5 Years Annual ROA >> Back to BTSG Management Effectiveness >> Compare BTSG ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 19
Sector	# 144
Overall	# 1036

Return On Assets Statistics
High	Average	Low
5.93 %	2.55 %	-0.36 %
(Jun 30 2026)		(Dec 31 2024)

Financial Statements
Brightspring Health Services Inc 's Assets	$ 6,102 million	BTSG's Balance sheet
Brightspring Health Services Inc 's Income	$ 84 million	Quarterly BTSG's Income Statement
BTSG's Income by Division		See BTSG's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	FY	FY	FY
Y / Y Total Assets Change	13.04 %	-	-	-	-
Total Assets in million	6,413	5,673	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	189	-21	0	0	0
Annual Return On Assets	2.95 %	-0.36 %	-	-	-

BTSG's 5 Years Annual ROA >> Back to BTSG Management Effectiveness >> Compare BTSG ROA to its Competitors

Comment on BTSG's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 2.95 % compared to prior year, due to annual net income growth of % to $189.11 million, while value of Brightspring Health Services Inc 's overall assets grew just by 13.04 % to $6,413.31 million, compared to $6,413.31 a year before.

More Return On Assets Ratios
BTSG's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BTSG's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BTSG's Competitors
Subscribers only: Roa for Brightspring Health Services Inc 's Suppliers
Subscribers only: Return On Assets for BTSG's Customers

You may also want to know
BTSG's Roi	BTSG's Inventory Turnover Ratio	BTSG's Growth Rates	BTSG's Dividend Comparisons
	BTSG's Profitability Ratios	BTSG's Asset Turnover Ratio	BTSG's Dividend Growth
BTSG's Roe	BTSG's Valuation Ratios	BTSG's Financial Strength Ratios	BTSG's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Alnylam Pharmaceuticals Inc	15.76 %
Intuitive Surgical Inc	15.63 %
Healthcare Services Group Inc	15.21 %
Inspire Medical Systems inc	15.21 %
Dexcom Inc	14.87 %
Neurocrine Biosciences Inc	14.73 %
Entera Bio Ltd	14.60 %
Standard Biotools Inc	14.31 %
Arcutis Biotherapeutics Inc	14.23 %
Harmony Biosciences Holdings inc	14.15 %
Biolife Solutions Inc	14.09 %
Aveanna Healthcare Holdings Inc	13.82 %
West Pharmaceutical Services Inc	13.64 %
Medinotec Inc	13.38 %
Puma Biotechnology Inc	13.28 %
Sbc Medical Group Holdings Incorporated	13.26 %
Alpha Pro Tech Ltd	13.17 %
Illumina Inc	12.68 %
Spero Therapeutics Inc	12.57 %
Transmedics Group Inc	12.50 %
Eton Pharmaceuticals Inc	12.37 %
Nephros Inc	12.30 %
Msa Safety Inc	12.23 %
Strata Critical Medical Inc	12.18 %
Insulet Corporation	12.13 %
Lantheus Holdings Inc	11.89 %
Ligand Pharmaceuticals Incorporated	11.68 %
Theravance Biopharma inc	11.68 %
Carlisle Companies Incorporated	11.62 %
Encompass Health Corporation	11.60 %

Date modified: 2026-09-12T06:27:28+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.